Screening compound: C21H21N3O6S (P681-0451)

Screening compound: C<sub>21</sub>H<sub>21</sub>N<sub>3</sub>O<sub>6</sub>S (P681-0451)
Screening compound: C<sub>21</sub>H<sub>21</sub>N<sub>3</sub>O<sub>6</sub>S (P681-0451) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C21H21N3O6S (P681-0451)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P681-0451

Molecular Formula

C21H21N3O6S (C21 H21 N3 O6 S)

Compound Name

5-methoxy-1-methyl-1'-[(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)sulfonyl]spiro[indole-3,3'-pyrrolidin]-2(1{H})-one

IUPAC name

5-methoxy-1-methyl-1'-[(3-methyl-2-oxo-23-dihydro-13-benzoxazol-6-yl)sulfonyl]-12-dihydrospiro[indole-33'-pyrrolidin]-2-one

SMILES

CN(C(C1(CC2)CN2S(c(cc2)cc(O3)c2N(C)C3=O)(=O)=O)=O)c(cc2)c1cc2OC

MDL Number (MFCD)

C21H21N3O6S (P681-0451) in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Hsp90-Targeted Library (11355 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Spiro Library (21655 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
  • Mimetics
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C21H21N3O6S (P681-0451) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C21H21N3O6S (P681-0451)?
Check Price and Availability of C21H21N3O6S (P681-0451), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C21H21N3O6S (P681-0451) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C21H21N3O6S (P681-0451)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C21H21N3O6S (P681-0451)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C21H21N3O6S (P681-0451) available by request